Search

Author/Creator Mackiewicz, Jacek

1. 307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study. (10th December 2020)

Authors:
Lewis, Karl; Ascierto, Paolo; Robert, Caroline; Munhoz, Rodrigo; Liszkay, Gabriella; Marino, Luis De La Cruz; Olah, Judit; Queirolo, Paola; Mackiewicz, Jacek; Shah, Kalpit; Forbes, Harper; Hertig, Christian; Yan, Yibing; Gutzmer, Ralf; McArthur, Grant
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A188
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study. (9th November 2020)

Authors:
Lewis, Karl; Ascierto, Paolo; Robert, Caroline; Munhoz, Rodrigo; Liszkay, Gabriella; Marino, Luis De La Cruz; Olah, Judit; Queirolo, Paola; Mackiewicz, Jacek; Shah, Kalpit; Forbes, Harper; Hertig, Christian; Yan, Yibing; Gutzmer, Ralf; McArthur, Grant
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A334
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients. Issue 1 (February 2021)

Authors:
Cybulska-Stopa, Bożena; Ziętek, Marcin; Kamińska-Winciorek, Grażyna; Czarnecka, Anna M.; Piejko, Karolina; Galus, Łukasz; Ziółkowska, Barbara; Kieszko, Stanisław; Kempa-Kamińska, Natasza; Calik, Jacek; Zemełka, Tomasz; Kubiatowski, Tomasz; Suwiński, Rafał; Mackiewicz, Jacek; Rutkowski, Piotr
Journal:
Melanoma research
Issue:
Volume 31:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma. Issue 5 (October 2020)

Authors:
Cybulska-Stopa, Bożena; Rogala, Paweł; Czarnecka, Anna M.; Galus, Łukasz; Dziura, Robert; Rajczykowski, Marcin; Kubiatowski, Tomasz; Wiśniewska, Magdalena; Gęga-Czarnota, Adrianna; Teterycz, Paweł; Ziobro, Marek; Suwiński, Rafał; Mackiewicz, Jacek; Rutkowski, Piotr
Journal:
Melanoma research
Issue:
Volume 30:Issue 5(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma. (19th May 2022)

Authors:
Cybulska-Stopa, Bożena; Ziętek, Marcin; Czarnecka, Anna M.; Piejko, Karolina; Dziura, Robert; Galus, Łukasz; Ziółkowska, Barbara; Kieszko, Stanisław; Kempa-Kamińska, Natasza; Calik, Jacek; Seredyńska, Joanna; Gądek, Kamila; Zemełka, Tomasz; Teterycz, Paweł; Kubiatowski, Tomasz; Suwiński, Rafał; M...
Journal:
Journal of dermatological treatment
Issue:
Volume 33:Number 4(2022)
Page Start:
2168
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors. Issue 5 (October 2018)

Authors:
Teterycz, Paweł; Jagodzińska-Mucha, Paulina; Cybulska-Stopa, Bożena; Mariuk-Jarema, Anna; Kozak, Katarzyna; Koseła-Paterczyk, Hanna; Czarnecka, Anna M.; Rajczykowski, Marcin; Dziura, Robert; Galus, Łukasz; Mackiewicz, Jacek; Świtaj, Tomasz; Klimczak, Anna; Falkowski, Slawomir; Suwiński, Rafał; Zi...
Journal:
Melanoma research
Issue:
Volume 28:Issue 5(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment. Issue 3 (3rd June 2023)

Authors:
Cybulska-Stopa, Bożena; Piejko, Karolina; Ostaszewski, Krzysztof; Dziura, Robert; Galus, Łukasz; Ziółkowska, Barbara; Kempa-Kamińska, Natasza; Ziętek, Marcin; Bal, Wiesław; Kamycka, Agnieszka; Dudzisz-Śledź, Monika; Kubiatowski, Tomasz; Kamińska-Winciorek, Grażyna; Suwiński, Rafał; Mackiewicz, Ja...
Journal:
Melanoma research
Issue:
Volume 33:Issue 3(2023)
Page Start:
208
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial. Issue 10336 (30th April 2022)

Authors:
Luke, Jason J; Rutkowski, Piotr; Queirolo, Paola; Del Vecchio, Michele; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; de la Cruz Merino, Luis; Khattak, Muhammad A; Schadendorf, Dirk; Long, Georgina V; Ascierto, Paolo A; Mandala, Mario; De Galitiis, Federica; Haydon, Andrew; Dummer, Reinhard; Grob, J...
Journal:
Lancet
Issue:
Volume 399:Issue 10336(2022)
Page Start:
1718
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial. Issue 11 (November 2022)

Authors:
Long, Georgina V; Luke, Jason J; Khattak, Muhammad A; de la Cruz Merino, Luis; Del Vecchio, Michele; Rutkowski, Piotr; Spagnolo, Francesco; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; Kirkwood, John M; Robert, Caroline; Grob, Jean-Jacques; de Galitiis, Federica; Schadendorf, Dirk; Carlino, Matteo ...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 11(2022)
Page Start:
1378
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results. Issue 1 (29th November 2018)

Authors:
Mackiewicz, Jacek; Burzykowski, Tomasz; Iżycki, Dariusz; Mackiewicz, Andrzej
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 6:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗